Literature DB >> 24440357

Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy.

Marika Pane1, Elena S Mazzone1, Lavinia Fanelli1, Roberto De Sanctis1, Flaviana Bianco1, Serena Sivo1, Adele D'Amico2, Sonia Messina3, Roberta Battini4, Marianna Scutifero5, Roberta Petillo5, Silvia Frosini4, Roberta Scalise1, Gianluca Vita3, Claudio Bruno6, Marina Pedemonte6, Tiziana Mongini7, Elena Pegoraro8, Francesca Brustia9, Alice Gardani9, Angela Berardinelli9, Valentina Lanzillotta7, Emanuela Viggiano5, Filippo Cavallaro3, Maria Sframeli3, Luca Bello10, Andrea Barp10, Serena Bonfiglio11, Enrica Rolle12, Giulia Colia2, Michela Catteruccia2, Concetta Palermo1, Grazia D'Angelo10, Antonella Pini11, Elena Iotti13, Ksenija Gorni12, Giovanni Baranello13, Lucia Morandi13, Enrico Bertini2, Luisa Politano5, MariaPia Sormani14, Eugenio Mercuri15.   

Abstract

The Performance of Upper Limb was specifically designed to assess upper limb function in Duchenne muscular dystrophy. The aim of this study was to assess (1) a cohort of typically developing children from the age of 3years onwards in order to identify the age when the activities assessed in the individual items are consistently achieved, and (2) a cohort of 322 Duchenne children and young adults to establish the range of findings at different ages. We collected normative data for the scale validation on 277 typically developing subjects from 3 to 25years old. A full score was consistently achieved by the age of 5years. In the Duchenne cohort there was early involvement of the proximal muscles and a proximal to distal progressive involvement. The scale was capable of measuring small distal movements, related to activities of daily living, even in the oldest and weakest patients. Our data suggest that the assessment can be reliably used in both ambulant and non ambulant Duchenne patients in a multicentric setting and could therefore be considered as an outcome measure for future trials.
Copyright © 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Duchenne muscular dystrophy; Upper limb

Mesh:

Year:  2013        PMID: 24440357     DOI: 10.1016/j.nmd.2013.11.014

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  27 in total

1.  Understanding adherence to noninvasive ventilation in youth with Duchenne muscular dystrophy.

Authors:  John E Pascoe; Hemant Sawnani; Brooke Hater; Mark Sketch; Avani C Modi
Journal:  Pediatr Pulmonol       Date:  2019-09-01

Review 2.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; David Brumbaugh; Laura E Case; Paula R Clemens; Stasia Hadjiyannakis; Shree Pandya; Natalie Street; Jean Tomezsko; Kathryn R Wagner; Leanne M Ward; David R Weber
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

3.  Magnetic resonance imaging of the proximal upper extremity musculature in boys with Duchenne muscular dystrophy.

Authors:  R J Willcocks; W T Triplett; S C Forbes; H Arora; C R Senesac; D J Lott; T R Nicholson; W D Rooney; G A Walter; K Vandenborne
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

4.  Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort.

Authors:  Rebecca J Willcocks; William D Rooney; William T Triplett; Sean C Forbes; Donovan J Lott; Claudia R Senesac; Michael J Daniels; Dah-Jyuu Wang; Ann T Harrington; Gihan I Tennekoon; Barry S Russman; Erika L Finanger; Barry J Byrne; Richard S Finkel; Glenn A Walter; H Lee Sweeney; Krista Vandenborne
Journal:  Ann Neurol       Date:  2016-02-19       Impact factor: 10.422

5.  Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.

Authors:  Sean C Forbes; Harneet Arora; Rebecca J Willcocks; William T Triplett; William D Rooney; Alison M Barnard; Umar Alabasi; Dah-Jyuu Wang; Donovan J Lott; Claudia R Senesac; Ann T Harrington; Erika L Finanger; Gihan I Tennekoon; John Brandsema; Michael J Daniels; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Radiology       Date:  2020-04-14       Impact factor: 11.105

6.  Motor outcome measures in patients with FKRP mutations: A longitudinal follow-up.

Authors:  Amber M Gedlinske; Carrie M Stephan; Shelley R H Mockler; Katie M Laubscher; Karla S Laubenthal; Cameron D Crockett; M Bridget Zimmerman; Katherine D Mathews
Journal:  Neurology       Date:  2020-08-06       Impact factor: 9.910

7.  Reachable workspace and performance of upper limb (PUL) in duchenne muscular dystrophy.

Authors:  Jay J Han; Evan de Bie; Alina Nicorici; Richard T Abresch; Colleen Anthonisen; Ruzena Bajcsy; Gregorij Kurillo; Craig M Mcdonald
Journal:  Muscle Nerve       Date:  2015-12-29       Impact factor: 3.217

8.  Disease course in mdx:utrophin+/- mice: comparison of three mouse models of Duchenne muscular dystrophy.

Authors:  Abby A McDonald; Sadie L Hebert; Matthew D Kunz; Steven J Ralles; Linda K McLoon
Journal:  Physiol Rep       Date:  2015-04

9.  A video game based hand grip system for measuring muscle force in children.

Authors:  Mark Gotthelf; DeWayne Townsend; William Durfee
Journal:  J Neuroeng Rehabil       Date:  2021-07-10       Impact factor: 4.262

10.  Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study.

Authors:  Abhinandan Batra; Donovan J Lott; Rebecca Willcocks; Sean C Forbes; William Triplett; Jahannaz Dastgir; Pomi Yun; A Reghan Foley; Carsten G Bönnemann; Krista Vandenborne; Glenn A Walter
Journal:  J Neuromuscul Dis       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.